Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

14results about How to "Good formulation stability" patented technology

Preparation of solid lipid microcapsule sun-screening agent and application of solid lipid microcapsule sun-screening agent in cosmetics

The invention relates to the technical field of cosmetics, in particular to preparation of a solid lipid microcapsule sun-screening agent and application of the solid lipid microcapsule sun-screening agent in cosmetics. The preparation method comprises the following steps: S1, pretreatment of a chemical sun-screening agent: dissolving and uniformly stirring lipid, an emulsifier, a crystalline sun-screening agent and a solvent at 72-78 DEG C to obtain a uniformly dispersed oil phase, the lipid is 2-5% of polyglycerol-10 stearate, the specific amount of the lipid is 3%, the emulsifier is 4-6% of stearyl alcohol polyether-21, the specific amount of the emulsifier is 5%, the specific amount of the solvent is 3%, the specific amount of the solvent is 3%, and the specific amount of the solvent is 5%; the sun-screening agent is prepared from the following components in percentage by weight: 7%-9% of bis-ethyl hexyloxyphenol methoxyphenyl triazine and 7%-9% of ethyl hexyltriazinone. According to the preparation of the solid lipid microcapsule sun-screening agent and the application of the solid lipid microcapsule sun-screening agent in cosmetics, the solid lipid microcapsule sun-screening agent is adopted and has excellent formula stability, safety and efficient sun-screening capacity, the sticky feeling of the sun-screening agent on the skin surface is effectively reduced, and the use experience feeling of a product is improved.
Owner:GUANGZHOU RUXI BIOTECHNOLOGY CO LTD

Composition for protecting micro-ecological balance of skin and preparation method thereof

The invention provides a composition for protecting micro-ecological balance of skin and a preparation method of the composition. Comprising the following components in percentage by weight: 84.12%-92.47% of a solvent, 5%-10% of a bifidus yeast fermentation product lysate, 0.1%-0.5% of tetrahydromethylpyrimidine carboxylic acid, 0.5%-1% of panthenol, 0.5%-1% of lactobacillus / soybean milk fermentation product filtrate, 0.5%-1% of arginine / lysine polypeptide, 0.5%-1% of 1, 2-hexanediol, 0.1%-0.5% of a pH regulator, 0.03%-0.08% of a chelating agent and 0.3%-0.8% of an antioxidant. According to the scheme, probiotic strains which are carefully screened are selected as powerful cell protection factors, an ideal environment for skin flora survival is kept, and the skin health level is improved.
Owner:SHAANXI JIABEINI BIOTECHNOLOGY CO LTD

A method for preparing a metformin compound hypoglycemic oral solution

This invention provides a method for preparing a metformin compound hypoglycemic oral solution, relating to the pharmaceutical field, comprising: step S1, pretreatment of traditional Chinese medicine components; step S2, enzymatic hydrolysis of the first group of traditional Chinese medicine components; step S3, supercritical extraction; step S4, preparation of mixed traditional Chinese medicines; step S5, preparation of inclusion complex; step S6, compound formulation; and step S7, post-processing. This method synergistically combines extracts from seven traditional Chinese medicines—bitter melon, phellodendron bark, astragalus root, kudzu root, rehmannia root, ginseng, and privet fruit—with metformin hydrochloride to form a metformin compound hypoglycemic oral solution, balancing the synergy, safety, and stability of traditional Chinese and Western medicines, thereby improving hypoglycemic effects while reducing the incidence of gastrointestinal adverse reactions to metformin.
Owner:CHONGQING CONQUER PHARML

Tofacitinib citrate composition

The invention relates to a tofacitinib citrate composition. The tofacitinib citrate composition is prepared by mixing active ingredients with a thickening agent, an osmotic pressure regulator, an adhesive and a lubricant, and then tabletting and coating. The tofacitinib citrate composition provided by the invention has the advantages of good stability and suitability for large-scale production.
Owner:CHENGDU KANGHONG PHARMACEUTICAL GROUP CO LTD

First treatment agent for regenerated cellulose fiber, treatment agent for regenerated cellulose fiber, composition containing first treatment agent for regenerated cellulose fiber, method for preparing dilution of treatment agent for regenerated cellulose fiber, method for treating regenerated cellulose fiber, and regenerated cellulose fiber

ActiveCN118140023BGood formulation stabilityPolymer scienceActive agent
The present invention aims to provide a first treatment agent for regenerated cellulose fibers having improved formulation stability. The first treatment agent for regenerated cellulose fibers of the present invention contains an iodine value of 1 gI 2 The first treatment agent for regenerated cellulose fibers is characterized in that it contains a sulfate ester salt (A) and an iodine value of less than 1 g / 100 g. 2 / 100g of nonionic surfactant (B1). The sulfate ester salt (A) is a neutralized salt of a reaction product of fat (a) and sulfuric acid and at least one selected from amines, alkali metals and alkaline earth metals.
Owner:TAKEMOTO OIL & FAT CO LTD

Pharmaceutical composition of pyridoimidazole thiopropionic acid compound crystal form 13 and preparation method of tablets of pharmaceutical composition

The invention relates to the technical field of pharmaceutical preparations, in particular to a pharmaceutical composition of a pyridoimidazole thiopropionic acid compound crystal form 13 and a preparation method of tablets of the pharmaceutical composition. The pharmaceutical composition is prepared from the following components in percentage by mass: a raw material medicine: 5-50% of pyridoimidazole thiopropionic acid compound crystal form Form13; the internally added auxiliary materials comprise 44%-89% of a filling agent, 2%-6% of a disintegrating agent and 1% of a flow aid; and an additional auxiliary material: 0.5%-2% of a lubricant. The preparation method comprises the steps of pretreatment, premixing, size stabilization, total mixing, tabletting and coating. According to the HY-0902 tablet, compounds of micronized raw material medicines (the particle size D90 is less than or equal to 10 microns) are preferably selected, and technical means of screening the types of auxiliary materials, limiting the proportion of the auxiliary materials in a certain range and the like are combined, so that the use of a solubilizer is avoided, meanwhile, the dissolution rate of the HY-0902 tablet is effectively improved, the stability is good, the production process is simple, and the production requirement is met.
Owner:SHANDONG HAIYA PHARMA TECH CO LTD

Synthesis method of cibopadol citrate

The invention relates to the technical field of biological medicines, and particularly discloses a synthesis method of cibopadol citrate, which has the advantages that no toxic solvent is used in the synthesis process, the environmental pollution is reduced, and the cost is reduced; the purification process of the intermediate in the synthesis process is simplified, so that the operation process is simplified, and the actual production is easier; a common solvent is used in the crystallization salt forming process, the operation process is simple, and industrial production is facilitated; the citrate can promote the medicine to be better released in vivo by improving the solubility of the medicine, so that the utilization degree and the effect of the medicine are improved; the citrate has better chemical stability, so that the citrate has better preparation stability; in addition, by optimizing the release characteristics of the drug (e.g., improving the sustained release mechanism), the citrate form may play a positive role in reducing the side effects of the drug.
Owner:WUHAN HENGSHIDI TECHNOLOGY CO LTD

Picloram triethanolamine salt aqueous auxiliary agent and preparation method thereof

The invention discloses an picloram triethanolamine salt water agent auxiliary agent and a preparation method thereof. The auxiliary agent is prepared from the following components in percentage by weight: 20-45% of dihydrogenated tallow dimethyl ammonium chloride, 10-20% of triethanolamine, 10-20% of sodium chloride, 5-10% of sodium chloride, 5-10% of sodium chloride and the balance of water. 15 to 30% of hydrogenated tallow amine acetate; 10 to 20% of hexadecyl dimethyl allyl ammonium chloride; 1-2% of dioctyl sodium sulfosuccinate; and the balance water. The picloram triethanolamine ammonium salt aqueous solution processed by the method is not easy to solidify at low temperature, has the characteristics of high efficiency, high environmental and biological safety, good preparation stability and the like, is particularly suitable for northern use, and has a good application prospect.
Owner:NANJING KEYI NEW MATERIALS

Cleaning product with repairing effect and preparation method thereof

The invention relates to the field of A61K8 / 18, in particular to a cleaning product with a repairing effect and a preparation method thereof.The cleaning product is at least prepared from, by mass, 40-60% of vegetable oil, 15-35% of anionic surfactant, 3-10% of zwitterionic surfactant and the balance emollient, the vegetable oil comprises fermented vegetable oil, and the zwitterionic surfactant comprises a zwitterionic surfactant and a zwitterionic surfactant. The skin can be repaired in the cleaning process, the formula cost, the raw material utilization rate and the formula stability are fully balanced, and the high market popularization value is achieved.
Owner:CHANGSHA BENXI CULTURAL CREATIVITY CO LTD

Diflufenican and pyroxasulfone pesticide suspending agent and preparation method thereof

PendingCN121970766ALarge particle sizeSolve the problem of poor formula stabilityBiocideAnimal repellantsSuspending AgentsOrganic chemistry
The invention relates to the field of pesticides, in particular to a diflufenican and pyroxasulfone pesticide suspending agent and a preparation method thereof. The diflufenican and pyroxasulfone pesticide suspending agent provided by the invention is prepared from the following raw materials in parts by mass: 7 to 10 parts of pyroxasulfone active compound, 10 to 15 parts of diflufenican active compound, 1 to 3 parts of wetting dispersant, 5 to 10 parts of dispersant, 1 to 3 parts of suspension thixotropic agent, 5 to 10 parts of antifreezing agent, 0.1 to 0.3 part of preservative, 0.1 to 0.3 part of thickening agent, 0.1 to 0.3 part of pH regulator, 0.1 to 0.3 part of defoaming agent and 60 to 80 parts of water. Through the synergistic effect of the auxiliary agents, the storage and application stability of the preparation is guaranteed, it is also guaranteed that the effective components are evenly distributed and efficiently absorbed by weeds, the green agriculture requirement is met, and the high practical and popularization price is achieved.
Owner:SINON CHEM CHINA

Oil-dispersed solid cosmetic composition for improving skin elasticity including caffeine and preparation method therefor

PendingEP4410271A4Good formulation stabilitysuperior skin elasticity improvement effectCosmetic preparationsToilet preparations
The present invention relates to an oil-dispersion solid cosmetic composition and a method for preparing the same, wherein the cosmetic composition can maintain a stabilized formulation while containing caffeine, and thus can be effectively used in the manufacture of a product for improving skin elasticity.
Owner:COSMAX INC

Oily cosmetic

PendingCN122180500ANo sticky feelingExcellent ease of useCosmetic preparationsMake-upPolymer sciencePolymer chemistry
To develop an oily cosmetic which contains a warming component and is excellent in non-stickiness, easiness in film thickness adjustment, and low stringiness. An oily cosmetic which contains the following components (A) to (D): (A) petrolatum, (B) a warming component, (C) a higher alcohol which is liquid at 25°C, and (D) a dextrin fatty acid ester.
Owner:KOSÉ HOLDINGS CO LTD

High-stability daptomycin composition for injection, and preparation method therefor and use thereof

PendingEP4285918A4Good formulation stabilityConvenient storage and transportationPowder deliveryAntibacterial agents
The present invention provides a high-stability daptomycin composition for injection and preparation method therefor and use thereof. The daptomycin composition for injection comprises daptomycin and a pharmaceutically acceptable carrier, and the pharmaceutically acceptable carrier contains a divalent metal salt, a pH regulator, and an osmotic pressure regulator; and the molar ratio of daptomycin to divalent metal salt in the daptomycin composition for injection is 1: 1.0 to 1: 3.5. The daptomycin composition for injection of the present invention significantly improves the stability of the preparation, facilitates the storage and transportation of the preparation at room temperature, and ensures the safety of drug use; And the preparation method of the present invention has advantages such as green environmental protection, suitability for industrialization.
Owner:ZHEJIANG NOVUS PHARMACEUTICALS CO LTD +1